PubRank

Dany Chalbos

Author PubWeight™ 19.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 2007 2.70
2 FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 2005 1.74
3 Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 2004 1.46
4 Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells. Mol Cell Biol 2009 1.22
5 Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. J Biol Chem 2007 1.19
6 Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol Cell Biol 2007 1.16
7 The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation. Cancer Res 2007 1.16
8 Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 2002 1.09
9 RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1. Mol Cell Biol 2009 0.98
10 Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer. Int J Cancer 2009 0.97
11 Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter. Eur J Biochem 2003 0.97
12 PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase. Cancer Res 2010 0.95
13 Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res 2012 0.94
14 Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. Mol Endocrinol 2003 0.93
15 PTPN13/PTPL1: an important regulator of tumor aggressiveness. Anticancer Agents Med Chem 2011 0.92
16 Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis. Int J Cancer 2007 0.85
17 The role of sex steroid receptors on lipogenesis in breast and prostate carcinogenesis: a viewpoint. Horm Cancer 2010 0.76